Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07283653

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Kate Hutcheson, PHD

CONTACT

[email protected]

713-792-6513

Kate Hutcheson, PHD

PRINCIPAL_INVESTIGATOR

About this study

Primary Objective Assess the impact of implementation strategies on clinical adoption (reach) of DIGEST for oncology MBS studies.

Secondary Objective Assess the impact of implementation strategies on the fidelity (reliability) of DIGEST adoption for oncology MBS studies

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A hospital or clinic affiliated with the Veteran's Affairs system, University of Wisconsin system, or Ohio State University system.
  • A minimum average of 10 Modified Barium Swallow (MBS) procedures per month in oncology patients in preceding year.
  • MBS imaging files are recorded and archived as a routine procedure (and accessible to researchers).

Exclusion criteria

N/A

Treatment and study plan

No intervention

Other

receive no active implementation

DIGEST Training Program

Other

Investigator led training program

DIGEST Training + Practice Facilitation

Other

Training plus practice facilitation

Primary outcomes

  1. Adoption of DIGEST in routine clinical documentation for oncology MBS studies

    Time frame: Through study completion; an average of 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Kate Hutcheson, PHD

CONTACT

[email protected]

713-792-6513

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2029
First posted
Dec 16, 2025
Registry last updated
Feb 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.